Adults on dupilumab for severe chronic rhinosinusitis with nasal polyps had better outcomes than those who used omalizumab, ...

The American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) published the new Clinical Practice ...

Chronic rhinosinusitis is inflammation of the sinuses and nasal passages that lasts at least 12 weeks. It causes ongoing symptoms, such as stuffy nose and facial pain or pressure.

Chronic rhinosinusitis is one of the most common clinical syndromes in the USA. The etiology of chronic rhinosinusitis is probably multifactorial, including infectious agents, ...

French pharma major Sanofi and US partner Regeneron Pharmaceuticals yesterday presented positive results from the EVEREST ...

Modeling data indicated that the greater predicted reduction of FeNO observed with verekitug, compared with published data for tezepelumab, is potentially driven by lower expression levels of the TSLP ...

In a new clinical practice guideline, recommendations are presented for the surgical management of chronic rhinosinusitis in adults.

Jennifer J. Shin, M.D., from Harvard Medical School in Boston, and colleagues developed 11 key action statements to aid clinicians in the surgical management of chronic rhinosinusitis in adults.

What makes the case unique: Since the 1930s, exostoses in the ear canal have been associated with surfing and other water activities that involve prolonged, repeated immersion in cold water.